Feb 23, 2026 08:02AM
Feb 23, 2026 08:00AM
Feb 10, 2026 08:00AM
Feb 10, 2026 08:00AM
Jan 7, 2026 07:00AM
Jan 6, 2026 07:01AM
Jan 6, 2026 07:00AM Genprex Announces Positive Preliminary Preclinical Data from Study of GPX-002 in Type 2 Diabetic Animal Studies
Nov 24, 2025 07:00AM
Nov 24, 2025 07:00AM
Nov 19, 2025 07:00AM
Nov 18, 2025 07:00AM
Nov 18, 2025 07:00AM
Nov 4, 2025 07:02AM
Nov 4, 2025 07:00AM Genprex Announces European Patent Office's Intent to Grant a Patent for the Combination of Reqorsa® Gene Therapy and PD-1 Antibodies to Treat Cancer
Oct 28, 2025 11:20AM
Oct 28, 2025 11:19AM
Oct 28, 2025 07:00AM
Oct 28, 2025 07:00AM
Oct 23, 2025 08:12AM
Oct 23, 2025 08:12AM
Oct 23, 2025 07:02AM Genprex collaborators to present lung cancer gene therapy data at conference
Oct 23, 2025 07:00AM
Oct 14, 2025 07:00AM
Sep 2, 2025 08:30AM
Aug 18, 2025 09:29AM
Aug 18, 2025 09:29AM
Aug 4, 2025 08:31AM
Aug 4, 2025 08:30AM Genprex Issues Stockholder Letter and Provides 2025 Corporate Update
Jun 24, 2025 09:25AM
Jun 24, 2025 09:25AM
Jun 23, 2025 09:00AM
Jun 3, 2025 07:00AM
May 29, 2025 07:00AM
May 28, 2025 07:00AM
May 7, 2025 07:00AM Genprex Signs Sponsored Research Agreement with the University of Pittsburgh to Study Diabetes Gene Therapy in Type 1 and Type 2 Diabetes
May 6, 2025 07:00AM
Apr 30, 2025 07:30AM
Apr 29, 2025 07:30AM
Apr 28, 2025 07:30AM
Apr 28, 2025 07:30AM
Apr 24, 2025 08:15AM
Apr 22, 2025 08:15AM Genprex (GNPX) Announces Research Collaborators' Abstract Published in Cancer Research Supplement Proceedings
Apr 22, 2025 08:15AM
Mar 26, 2025 08:16AM
Mar 26, 2025 08:15AM
Mar 25, 2025 08:15AM
Mar 4, 2025 08:15AM
Feb 19, 2025 08:16AM
Feb 19, 2025 08:15AM Genprex Advances Diabetes Program with Addition of Research Focused on Non-Viral Delivery System
Feb 18, 2025 08:16AM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All